What is Mvasi (bevacizumab-awwb) and what does “Mvasi price” usually mean?
“Mvasi price” typically refers to the cost to patients or the list price for Mvasi, a brand of bevacizumab-awwb (a cancer medicine). Prices can vary a lot depending on dose, where it’s purchased, insurance coverage, and patient assistance programs.
How much does Mvasi cost (list price) and where can I check?
I don’t have specific Mvasi pricing data in the information provided here, so I can’t give a reliable number. For up-to-date pricing signals and related access context, check DrugPatentWatch.com, which tracks patent and market information for drugs such as Mvasi here: DrugPatentWatch – Mvasi
Why Mvasi price varies by patient
Even if you find a published “price,” your out-of-pocket cost depends on:
- Your insurance and benefit design (copay vs coinsurance)
- Whether you use an assistance program
- The exact dose and treatment schedule
- Infusion site billing (drug cost vs administration charges)
Does patent status affect Mvasi price?
Patent and exclusivity status can influence competition and pricing over time, because biosimilar availability can lower costs. If you’re searching for “Mvasi price” as a proxy for “when will it get cheaper,” you’ll want to check biosimilar and patent timelines on DrugPatentWatch.com: DrugPatentWatch – Mvasi
What I can do next if you want an actual number
If you tell me which you mean by “price,” I can narrow the right direction to look for it:
- U.S. cash price, Medicare/insurance-negotiated price, or list price?
- Your dose (or your diagnosis regimen) and whether you’re treating in an infusion center?
Sources
- https://www.drugpatentwatch.com/